Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Alzheimer's disease
Colin L. Masters, Randall J. Bateman, Kaj Blennow, et al.
Nature Reviews Disease Primers (2015) Vol. 1, Iss. 1
Closed Access | Times Cited: 1426

Showing 1-25 of 1426 citing articles:

The neuropathological diagnosis of Alzheimer’s disease
Michael DeTure, Dennis W. Dickson
Molecular Neurodegeneration (2019) Vol. 14, Iss. 1
Open Access | Times Cited: 2352
Single-cell transcriptomic analysis of Alzheimer’s disease
Hansruedi Mathys, José Dávila-Velderrain, Zhuyu Peng, et al.
Nature (2019) Vol. 570, Iss. 7761, pp. 332-337
Open Access | Times Cited: 2016
Donanemab in Early Alzheimer’s Disease
Mark A. Mintun, Albert Lo, Cynthia Evans, et al.
New England Journal of Medicine (2021) Vol. 384, Iss. 18, pp. 1691-1704
Open Access | Times Cited: 1034
Biomarkers for Alzheimer's disease: current status and prospects for the future
Kaj Blennow, Henrik Zetterberg
Journal of Internal Medicine (2018) Vol. 284, Iss. 6, pp. 643-663
Open Access | Times Cited: 768
Biomarkers for neurodegenerative diseases
Oskar Hansson
Nature Medicine (2021) Vol. 27, Iss. 6, pp. 954-963
Open Access | Times Cited: 717
Gut Microbiota is Altered in Patients with Alzheimer’s Disease
Zhen‐Qian Zhuang, Lin‐Lin Shen, Weiwei Li, et al.
Journal of Alzheimer s Disease (2018) Vol. 63, Iss. 4, pp. 1337-1346
Closed Access | Times Cited: 696
Alzheimer's disease drug development pipeline: 2018
Jeffrey L. Cummings, Garam Lee, Aaron Ritter, et al.
Alzheimer s & Dementia Translational Research & Clinical Interventions (2018) Vol. 4, Iss. 1, pp. 195-214
Open Access | Times Cited: 676
NAD+ metabolism: pathophysiologic mechanisms and therapeutic potential
Na Xie, Lu Zhang, Wei Gao, et al.
Signal Transduction and Targeted Therapy (2020) Vol. 5, Iss. 1
Open Access | Times Cited: 639
CSF biomarkers of Alzheimer's disease concord with amyloid‐β PET and predict clinical progression: A study of fully automated immunoassays in BioFINDER and ADNI cohorts
Oskar Hansson, John Seibyl, Erik Stomrud, et al.
Alzheimer s & Dementia (2018) Vol. 14, Iss. 11, pp. 1470-1481
Open Access | Times Cited: 614
A randomized, double-blind, phase 2b proof-of-concept clinical trial in early Alzheimer’s disease with lecanemab, an anti-Aβ protofibril antibody
Chad J. Swanson, Yong Zhang, Shobha Dhadda, et al.
Alzheimer s Research & Therapy (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 589
Randomized Trial of Verubecestat for Mild-to-Moderate Alzheimer’s Disease
Michael Egan, James Kost, Pierre N. Tariot, et al.
New England Journal of Medicine (2018) Vol. 378, Iss. 18, pp. 1691-1703
Open Access | Times Cited: 583
Age, APOE and sex: Triad of risk of Alzheimer’s disease
Brandalyn C. Riedel, Paul M. Thompson, Roberta Dı́az Brinton
The Journal of Steroid Biochemistry and Molecular Biology (2016) Vol. 160, pp. 134-147
Open Access | Times Cited: 523
Alzheimer's disease drug development pipeline: 2020
Jeffrey L. Cummings, Garam Lee, Aaron Ritter, et al.
Alzheimer s & Dementia Translational Research & Clinical Interventions (2020) Vol. 6, Iss. 1
Open Access | Times Cited: 498
Common brain disorders are associated with heritable patterns of apparent aging of the brain
Tobias Kaufmann, Dennis van der Meer, Nhat Trung Doan, et al.
Nature Neuroscience (2019) Vol. 22, Iss. 10, pp. 1617-1623
Open Access | Times Cited: 486
Randomized Trial of Verubecestat for Prodromal Alzheimer’s Disease
Michael Egan, James Kost, Tiffini Voss, et al.
New England Journal of Medicine (2019) Vol. 380, Iss. 15, pp. 1408-1420
Open Access | Times Cited: 477
Transfer of a healthy microbiota reduces amyloid and tau pathology in an Alzheimer’s disease animal model
Min‐Soo Kim, Yoonhee Kim, Hyunjung Choi, et al.
Gut (2019) Vol. 69, Iss. 2, pp. 283-294
Closed Access | Times Cited: 471
Current state of Alzheimer’s fluid biomarkers
José Luís Molinuevo, Scott Ayton, Richard Batrla, et al.
Acta Neuropathologica (2018) Vol. 136, Iss. 6, pp. 821-853
Open Access | Times Cited: 444
Bidirectional relationship between sleep and Alzheimer’s disease: role of amyloid, tau, and other factors
Chanung Wang, David M. Holtzman
Neuropsychopharmacology (2019) Vol. 45, Iss. 1, pp. 104-120
Open Access | Times Cited: 427
Microglia-mediated T cell infiltration drives neurodegeneration in tauopathy
Xiaoying Chen, Maria Firulyova, Melissa Manis, et al.
Nature (2023) Vol. 615, Iss. 7953, pp. 668-677
Open Access | Times Cited: 329
Applications of focused ultrasound in the brain: from thermoablation to drug delivery
Ying Meng, Kullervo Hynynen, Nir Lipsman
Nature Reviews Neurology (2020) Vol. 17, Iss. 1, pp. 7-22
Closed Access | Times Cited: 324
Impairments of neural circuit function in Alzheimer's disease
Marc Aurel Busche, Arthur Konnerth
Philosophical Transactions of the Royal Society B Biological Sciences (2016) Vol. 371, Iss. 1700, pp. 20150429-20150429
Open Access | Times Cited: 319
Neuroimmune Axes of the Blood–Brain Barriers and Blood–Brain Interfaces: Bases for Physiological Regulation, Disease States, and Pharmacological Interventions
Michelle A. Erickson, William A. Banks
Pharmacological Reviews (2018) Vol. 70, Iss. 2, pp. 278-314
Open Access | Times Cited: 302
Comprehensive review of mechanisms of pathogenesis involved in Alzheimer’s disease and potential therapeutic strategies
Piyoosh Sharma, Pavan Srivastava, Ankit Seth, et al.
Progress in Neurobiology (2018) Vol. 174, pp. 53-89
Closed Access | Times Cited: 285
The Role of Mitochondria in Neurodegenerative Diseases: the Lesson from Alzheimer’s Disease and Parkinson’s Disease
Giacomo Monzio Compagnoni, Alessio Di Fonzo, Stefania Corti, et al.
Molecular Neurobiology (2020) Vol. 57, Iss. 7, pp. 2959-2980
Open Access | Times Cited: 278
Alzheimer’s Disease and Vascular Aging
Marta Cortés‐Canteli, Costantino Iadecola
Journal of the American College of Cardiology (2020) Vol. 75, Iss. 8, pp. 942-951
Open Access | Times Cited: 277
Page 1 - Next Page

Scroll to top